Article Cited by others


Intronic SNPs of TP53 gene in chronic myeloid leukemia: Impact on drug response

Sailaja K, Rao V R, Yadav Satish, Reddy R Rajasekhar, Surekha D, Rao D Nageswara, Raghunadharao D, Vishnupriya S

Year : 2012| Volume: 3| Issue : 2 | Page no: 182-185

   This article has been cited by
1 Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients
Krithika Bhuvaneshwar,Michael Harris,Yuriy Gusev,Subha Madhavan,Ramaswamy Iyer,Thierry Vilboux,John Deeken,Elizabeth Yang,Sadhna Shankar
BMC Cancer. 2019; 19(1)
[Pubmed]  [Google Scholar] [DOI]
2 Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer
Yu-Hsiang Lin,Yi-Hsuan Hsiao,Shun-Fa Yang,Yu-Fan Liu,Chun-Fang Hsu,Po-Hui Wang
Reproductive Sciences. 2018; 25(11): 1549
[Pubmed]  [Google Scholar] [DOI]
3 ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure
Justine E. Marum,David T. Yeung,Leanne Purins,John Reynolds,Wendy T. Parker,Doris Stangl,Paul P. S. Wang,David J. Price,Jonathan Tuke,Andreas W. Schreiber,Hamish S. Scott,Timothy P. Hughes,Susan Branford
Blood Advances. 2017; 1(18): 1369
[Pubmed]  [Google Scholar] [DOI]
4 Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response
Juan Chen,Ji-Ye Yin,Xiang-Ping Li,Ying Wang,Yi Zheng,Chen-Yue Qian,Hui He,Chao Fang,Zhan Wang,Yu Zhang,Ling Xiao,Sai-Ying Wang,Wei Zhang,Hong-Hao Zhou,Zhao-Qian Liu
Clinical Lung Cancer. 2015; 16(4): 298
[Pubmed]  [Google Scholar] [DOI]


Read this article